SCHEMBL869807

SCHEMBL869807

C1COC(OC2COCCO2)CO1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11525387 0.82 CHRM2 (0.33) CHRM2CHRM4CHRM5CHRM3
SCHEMBL28477665 0.81
SCHEMBL28469423 0.81
SCHEMBL28289855 0.80
SCHEMBL8895005 0.78
SCHEMBL670442 0.78
SCHEMBL10455008 0.78
SCHEMBL12460113 0.78
SCHEMBL14660501 0.78
SCHEMBL27813850 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025053792-A1 COLLECTIVE SYNTHESIS OF PHANTOMOLIN FAMILY THROUGH TOTAL SYNTHESIS OF THE SESQUITERPENE LACTONE MOLEPHANTIN NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2025-03-13 WO claimed
US-20230049294-A1 STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES Atea Pharmaceuticals, Inc. (US) 2023-02-16 US claimed
CN-115124051-A Preparation method and application of fluorosulfonate 上海如鲲新材料股份有限公司 2022-09-30 CN claimed
CN-108075182-B Method for manufacturing sulfide-based solid electrolyte by wet process 现代自动车株式会社 2022-07-22 CN claimed
WO-2021216722-A1 STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES Atea Pharmaceuticals, Inc. (US) 2021-10-28 WO claimed
CN-107108442-A Process and intermediates for preparing alpha, omega-dicarboxylic acid terminated dialkyl ethers 燿石治疗公司 2017-08-29 CN claimed
US-9403162-B2 Ionomers with ionic groups in the side chain Häring, Thomas (DE) 2016-08-02 US claimed
CN-101724291-B Novel reactive dyes with dioxane ether bridge group ETHICAL INTERNAT TRADING & WAREHOUSING SHANGHAI CO LTD 2015-06-10 CN claimed
CN-104003838-A Synthetic method of adapalene UNIV EAST CHINA SCIENCE & TECH 2014-08-27 CN claimed
CN-101631814-B Adhesive useful for installing vehicle windows DOW GLOBAL TECHNOLOGIES INC 2012-12-19 CN claimed
CN-102503855-A Synthetic method of 4-cyanobiphenyl UNIV EAST CHINA SCIENCE & TECH 2012-06-20 CN claimed
EP-1979362-B1 NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA COMMISSARIAT ENERGIE ATOMIQUE (FR) 2010-12-15 EP claimed
CN-101724291-A Novel reactive dyes with dioxane ether bridge group ETHICAL INTERNAT TRADING & WAR 2010-06-09 CN claimed
CN-101631814-A Adhesive useful for installing vehicle windows DOW GLOBAL TECHNOLOGIES INC 2010-01-20 CN claimed
US-20090005269-A1 Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-01-01 US claimed
EP-1979362-A1 NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-10-15 EP claimed
CN-101100572-A Ink jet ink composition and ink box containing the same INT UNITED TECHNOLOGY CO LTD (CN) 2008-01-09 CN claimed
WO-2007088186-A1 NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2007-08-09 WO claimed
EP-3494996-B1 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS AGENSYS INC (US) 2026-04-15 EP disclosed
US-3935254-A 5C-PROSTEN-13-YNOIC ACIDS CARLO ERBA S.P.A. (IT) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005269-A1 Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports SELE, ELANE, EPCAM CHRM2 3192/4885CHRM4 3733/4885CHRM5 3363/4885
US-20230049294-A1 STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES NUDT1, PNP, ITPA CHRM2 4385/4885CHRM4 3748/4885CHRM5 4232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.